This test is most useful if any of these apply to you.
If you have ever dealt with recurring vaginal odor, unusual discharge, or a stubborn case of bacterial vaginosis that keeps coming back, this is the bacterium at the center of the story. A vaginal swab measuring Gardnerella vaginalis tells you how much of this organism is present in your vaginal microbial community, and that single piece of information can reframe what your symptoms actually mean.
The catch is that Gardnerella is common in many women without any symptoms at all. What separates a normal finding from a meaningful one is the load, the mix of strains, and what other bacteria are alongside it. Reading this result well means understanding when high levels actually signal trouble.
Gardnerella vaginalis (often shortened to G. vaginalis) is a bacterium, not a hormone or chemical your body makes. It lives on the lining of the vagina, and sometimes the cervix, as part of the broader community of microbes that share that space. The test on a vaginal swab counts how much of its DNA is present, often as part of a panel that also measures Lactobacillus species and other bacteria linked to bacterial vaginosis (BV).
Many Gardnerella strains produce an enzyme called sialidase, which breaks down the protective mucus layer that lines the vagina. Strains carrying this enzyme are the ones most strongly linked to BV and to the sticky bacterial film, called a biofilm, that coats vaginal cells in BV. Strains without sialidase are more often found in women without BV.
This test is most useful as part of diagnosing or tracking bacterial vaginosis, the most common cause of abnormal vaginal discharge and odor in women of reproductive age. A healthy vaginal community is usually dominated by Lactobacillus species, which keep the environment acidic and inhospitable to other microbes. BV is what happens when that protective layer thins out and a mix of anaerobic bacteria, with Gardnerella often at the center, takes over.
In one study tracking women with repeated vaginal swabs, a sharp rise in Gardnerella abundance preceded a new BV diagnosis, suggesting this organism plays an active role in tipping the community into BV rather than just showing up afterward. Diagnostic panels that count all four major Gardnerella strain groups distinguish BV-type microbiota from normal microbiota with high accuracy, better than measuring the sialidase gene alone.
What this means for you: a single positive result for Gardnerella does not mean you have BV. The whole picture matters, including how much is present, whether multiple strains are detected, and what else is growing alongside it.
If you have BV and start treatment, what happens to Gardnerella matters for whether the BV stays gone. After five days of intravaginal metronidazole gel, women whose BV resolved showed roughly a thousand to ten thousand fold drop in Gardnerella by one month, while women whose BV persisted showed almost no change. In other research, persistently high Gardnerella after antibiotics was linked to higher odds of BV coming back within a month.
There is also a biofilm wrinkle. In a small biopsy study, even when symptoms cleared after a week of oral metronidazole, an adherent Gardnerella-dominated biofilm sometimes stayed attached to the vaginal lining and resurged later. This helps explain why BV recurrence is so common even after textbook treatment.
Higher Gardnerella loads and the presence of multiple strain groups, especially clade 2, have been linked to BV during pregnancy and to broader shifts away from a Lactobacillus-dominated community. In an analysis of women with HPV infection, high-risk HPV infection and cervical lesions were associated with increased Gardnerella and Prevotella in the vaginal microbiota. In another study of women with high-grade cervical lesions (CIN2), those with a Lactobacillus-dominant microbiome were more likely to see their lesions regress on their own.
These are associations, not proof that Gardnerella itself causes HPV persistence or pregnancy complications. But they fit a consistent pattern where a Gardnerella-heavy, low-Lactobacillus environment is a less hospitable backdrop for several aspects of reproductive health.
In a prospective study of African couples, women with BV had more than a three-fold increased risk of transmitting HIV to a male partner compared with women without BV. A meta-analysis found that women with BV had nearly a two-fold higher risk of acquiring Trichomonas vaginalis infection. Another meta-analysis showed BV is associated with a significantly increased risk of acquiring herpes simplex virus type 2. These outcomes are tied to the broader BV state rather than to Gardnerella alone, but Gardnerella is one of the most consistent markers of that state.
The vaginal microbiome shifts constantly. It changes across the menstrual cycle, after sexual activity, with new partners, with hormonal contraception, and during pregnancy. A single Gardnerella count is a snapshot, not a verdict. Studies that track women over weeks show Gardnerella levels can rise and fall meaningfully across short windows, which is part of why incident BV can be predicted by watching the trajectory rather than relying on one reading.
A reasonable approach is to test when you have symptoms or active concern, retest about a month after any treatment to confirm Gardnerella has actually dropped, and if you have a history of recurrence, retest at three to six months even when you feel fine. The goal is to catch a brewing imbalance before it produces symptoms, not to chase a single number.
Several factors can distort a single reading and lead to the wrong conclusion. The most common ones cluster around what you have been doing in the days before the swab and what else is happening in your body.
If your result shows high Gardnerella, the next step is not to start antibiotics on the spot. The first move is to ask whether you have symptoms, what the rest of the panel shows (Lactobacillus, Atopobium or Fannyhessea vaginae, Megasphaera, Prevotella), and whether a Nugent score or Amsel criteria are available. A high Gardnerella with low Lactobacillus and multiple co-occurring BV-associated organisms is a different clinical picture than high Gardnerella with preserved Lactobacillus crispatus.
If you are symptomatic, working with a clinician on a standard course of metronidazole or clindamycin is the established path. If you have recurrent BV, ask about post-treatment retesting to confirm Gardnerella actually dropped, and consider talking with your clinician about adjunct probiotic strategies that have shown effect in trials. If you are pregnant or trying to conceive, BV should be addressed because of the associations with preterm birth and infection acquisition. If you are asymptomatic and Gardnerella is detected at modest levels alongside a Lactobacillus-dominated community, this is often a normal finding in healthy women, and immediate treatment is not supported by evidence.
Evidence-backed interventions that affect your Gardnerella Vaginalis level
Gardnerella Vaginalis is best interpreted alongside these tests.
Gardnerella Vaginalis is included in these pre-built panels.